Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEShareholders meetingMgmt Change21 Jul 2026

Cambridge Technology Enterprises Limited

Shareholders meeting

Cambridge Technology Enterprises Limited has informed the Exchange regarding Notice of Postal Ballot for seeking approval of the Members on the appointment of Mr. Vivek Kumar Singh as Non-Executive and Independent Director of the Company.

Read more →📎 1 attachment
NSEAppointmentMgmt Change21 Jul 2026

Arihant Superstructures Limited

Appointment

Arihant Superstructures Limited has appointed Dr. Raghuveer Singh Rajpurohit as an Independent Director of the company, effective July 21, 2026, for a period of 5 years.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveFundraise21 Jul 2026

Gabriel India Limited

Outcome of Board Meeting

Gabriel India Limited's Board of Directors approved the un-audited financial results for the quarter ended June 30, 2026, and also approved the preferential allotment of equity shares to Asia Investments Private Limited for consideration other than cash, as part of the acquisition of HL MANDO ANAND India Private Limited. The company will issue and allot 1,44,04,204 equity shares to Asia Investments Private Limited at an issue price of INR 1,305.89 per equity share, aggregating to INR 18,81,03,05,962/-, and will also discharge the balance consideration of INR 3,50,00,00,953/- by way of cash consideration.

Read more →📎 1 attachment
NSEInvestor PresentationResults21 Jul 2026

Medplus Health Services Limited

Investor Presentation

Medplus Health Services Limited has announced its Q1 FY27 results, with revenue growing 21.8% YoY and 0.8% QoQ, but gross margin decreasing by 160 bps YoY and 200 bps QoQ. Operating EBITDA margin decreased by 120 bps YoY and 230 bps QoQ. The company added 146 new stores, including 131 new franchisees, during the quarter.

Read more →📎 1 attachment
NSEChange in Director(s)Mgmt Change21 Jul 2026

Arihant Superstructures Limited

Change in Director(s)

Arihant Superstructures Limited has informed the Exchange regarding Change in Director(s) of the company. The company has approved the appointment of Dr. Raghuveer Singh Rajpurohit as an Additional Director categorized as Non-Executive and Independent Director for a period of 5 (five) consecutive years.

Read more →📎 1 attachment
NSEChange in ManagementMgmt Change21 Jul 2026

Arihant Superstructures Limited

Change in Management

Arihant Superstructures Limited has informed the Exchange about the appointment of Dr. Raghuveer Singh Rajpurohit as an Additional Director categorized as Non-Executive and Independent Director of the Company.

Read more →📎 1 attachment
NSEShareholders meetingResults21 Jul 2026

Mahindra & Mahindra Financial Services Limited

Shareholders meeting

Mahindra & Mahindra Financial Services Limited has held its 36th Annual General Meeting through video conferencing, where all directors were present and various resolutions were passed, including the re-appointment of a director, appointment of a new director, and declaration of a dividend.

Read more →📎 1 attachment
NSEGeneral Updates21 Jul 2026

Jubilant Foodworks Limited

General Updates

Jubilant FoodWorks Limited has informed the Exchange about Submission of Communication letter sent to the shareholders for transfer of equity shares to Investor Education & Protection Fund.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults21 Jul 2026

Trident Limited

Outcome of Board Meeting

Trident Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and announced the incorporation of a new domestic wholly owned subsidiary to enhance brand presence and drive business development initiatives.

Read more →📎 1 attachment
NSECredit RatingRating Change21 Jul 2026

Godrej Properties Limited

Credit Rating

Godrej Properties Limited has informed the Exchange about the full repayment of Non-Convertible Debentures (NCDs) worth Rs. 750 crore, rated by ICRA Limited, on maturity dated July 03, 2026. The rating assigned by ICRA to the proposed/existing NCDs of the Company amounting to Rs. 5,250 crore remains unchanged.

Read more →📎 1 attachment
NSEPress Release (Revised)Results21 Jul 2026

Anthem Biosciences Limited

Press Release (Revised)

Anthem Biosciences Limited has revised its press release for Q1FY27 unaudited consolidated financial results, with consolidated revenue from operations at ₹4,182 Mn, EBITDA at ₹1,755 Mn, and PAT at ₹1,199 Mn.

Read more →📎 1 attachment
← PreviousPage 1174 of 2049Next →